Cluster Headache Treatment With Rimegepant

Status:
Not yet recruiting

Trial end date:
2023-12-01

Target enrollment:

Participant gender:

The purpose of this research is to explore the efficacy of rimegepant as a preventative therapy for cluster headache.

Phase 2

Mayo Clinic